Year-over-year earnings per share growth for the last twelve months: imdxinc.com (IMDX)
The investment potential of Insight Molecular Diagnostics (IMDX) is based on the creation of affordable and rapid precision tests for the mass market. The quarterly EPS change scale visualizes this trend, where -0.70 indicates the current level. Efficiency is confirmed by the integration of software and test systems into a single ecosystem, as well as strict compliance with environmental regulations regarding the disposal of chemical waste.
Summary analytical data breakdowns for Insight Molecular Diagnostics (IMDX)
- share price and expert price forecast:
- company stock exchange capitalization indicators:
- book capitalization data:
- debt level and financial liquidity data:
Debt to Equity Insight Molecular Diagnostics|IMDX - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Capital imdxinc.com|IMDX - Company Total Debt Obligations|Debts to Book Capitalization Insight Molecular|IMDX - Long-Term Indebtedness|Company Short-Term Debts Insight Molecular Diagnostics|Quick Liquidity Indicator imdxinc.com
- earnings and valuation multiples indicators:
IMDX - Profit After Payment of Taxes|Future Profit Insight Molecular Diagnostics|IMDX - Company Value to Net Income|Future Price to Earnings imdxinc.com|IMDX - Price/Earnings to Growth Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Insight Molecular|IMDX - Profit before interest, taxes and amortization|Earnings per share for the last twelve months Insight Molecular Diagnostics|IMDX - Earnings per share for the last twelve months|Quarterly EPS earnings growth imdxinc.com|IMDX - Earnings per share growth rate in current year|Earnings growth forecast for next year Insight Molecular Diagnostics
Analysis of all company metrics:Insight Molecular Diagnostics, Inc. - IMDX
This indicator measures the quarterly dynamics of net earnings per share, allowing for an assessment of capital resilience against external market shocks. By analyzing the percentage change in quarterly EPS, an investor determines the extent to which biomarker patent protection and high CLIA certification barriers translate into real profitability growth for Insight Molecular Diagnostics (IMDX) relative to operating expenses.
Competitors of Insight Molecular Diagnostics
A: Quarterly EPS earnings growth|DGX - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Illumina Corp|Exact Sciences Inc. (EXAS) - Year-over-year net earnings per share change for the last twelve months|Quarterly EPS earnings growth RVTY|Year-over-year net earnings per share change for the last twelve months bio-rad.com|Year-over-year earnings per share growth for the last twelve months Anbio NNNN|SHC: Year-over-year earnings per share growth for the last 12 months|QDEL - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share change for the last twelve months OPKO Health Corp. OPK|CDNA: Quarterly EPS earnings growth|MRVI - Year-over-year net earnings per share change for the last twelve months|FLGT (Fulgent Genetics) - Quarterly EPS earnings growth|LAB - Net earnings per share growth for the trailing year|Quarterly EPS earnings growth CTKB|OSUR (OraSure Corp) - Year-over-year earnings per one share growth for the last 12 months|Exagen - Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per share growth rate for the last twelve months MDXH (mdxhealth.com)|LUCD: Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per one share growth for the last 12 months PRE (Prenetics Global)|trinitybiotech.com (TRIB) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share growth for the last 12 months ProPhase Labs Corp|Year-over-year earnings per share growth for the last twelve months Ainos, Inc.|Earnings per share growth in annualized terms for the last twelve months codiagnostics.com CODX|Year-over-year earnings per share growth for the last twelve months HeartSciences (HSCS)|Year-over-year earnings per share growth for the last twelve months BMRA (Biomerica Inc.)|Quarterly EPS earnings growth CDIO (Cardio Diagnostics Holdings)|Onconetix Corporation (ONCO) - Earnings per share growth in annualized terms for the last twelve months|Virax Biolabs Group - Quarterly EPS earnings growth|bluejaydx.com (BJDX) - Year-over-year net earnings per share growth for the last 12 months|AWH (Aspira Women's Health Inc.) - Year-over-year net earnings per share growth for the last 12 months|Accelerate Diagnostics Inc. (AXDX) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last twelve months CENTOGENE|Year-over-year earnings per share growth for the last twelve months ENZ|Quarterly EPS earnings growth FRES|Quarterly EPS earnings growth gtglabs.com (GENE)|Year-over-year earnings per share growth for the last twelve months 23andMe ME|Year-over-year earnings per one share growth for the last 12 months PMD
